DK1003477T3 - Transdermalt terapeutisk system (TTS) indeholdende ammoniogruppeholdige (meth)acrylatpolymerer til administration af levonorgestrel - Google Patents

Transdermalt terapeutisk system (TTS) indeholdende ammoniogruppeholdige (meth)acrylatpolymerer til administration af levonorgestrel

Info

Publication number
DK1003477T3
DK1003477T3 DK98939602T DK98939602T DK1003477T3 DK 1003477 T3 DK1003477 T3 DK 1003477T3 DK 98939602 T DK98939602 T DK 98939602T DK 98939602 T DK98939602 T DK 98939602T DK 1003477 T3 DK1003477 T3 DK 1003477T3
Authority
DK
Denmark
Prior art keywords
levonorgestrel
tts
meth
administration
therapeutic system
Prior art date
Application number
DK98939602T
Other languages
Danish (da)
English (en)
Inventor
Hans-Michael Wolff
Christoph Arth
Original Assignee
Sanol Arznei Schwarz Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanol Arznei Schwarz Gmbh filed Critical Sanol Arznei Schwarz Gmbh
Application granted granted Critical
Publication of DK1003477T3 publication Critical patent/DK1003477T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
DK98939602T 1997-07-04 1998-07-02 Transdermalt terapeutisk system (TTS) indeholdende ammoniogruppeholdige (meth)acrylatpolymerer til administration af levonorgestrel DK1003477T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19728516A DE19728516C2 (de) 1997-07-04 1997-07-04 TTS zur Verabreichung von Levonorgestrel und gegebenenfalls Estradiol
PCT/EP1998/004079 WO1999001109A2 (de) 1997-07-04 1998-07-02 Transdermales therapeutisches system (tts) zur verabreichung von levonorgestrel

Publications (1)

Publication Number Publication Date
DK1003477T3 true DK1003477T3 (da) 2003-07-28

Family

ID=7834590

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98939602T DK1003477T3 (da) 1997-07-04 1998-07-02 Transdermalt terapeutisk system (TTS) indeholdende ammoniogruppeholdige (meth)acrylatpolymerer til administration af levonorgestrel

Country Status (17)

Country Link
US (1) US6555131B1 (es)
EP (1) EP1003477B1 (es)
JP (1) JP2002510315A (es)
KR (1) KR100381997B1 (es)
CN (1) CN1269717A (es)
AT (1) ATE236623T1 (es)
AU (1) AU749326B2 (es)
BR (1) BR9815510A (es)
CA (1) CA2294788C (es)
DE (2) DE19728516C2 (es)
DK (1) DK1003477T3 (es)
ES (1) ES2197495T3 (es)
IL (1) IL133762A0 (es)
NZ (1) NZ502351A (es)
PT (1) PT1003477E (es)
WO (1) WO1999001109A2 (es)
ZA (1) ZA985863B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19918106A1 (de) 1999-04-22 2000-10-26 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit neutralisierten Acrylathaftklebern
FR2795326B1 (fr) * 1999-06-28 2001-08-31 Adir Composition pharmaceutique solide thermoformable a liberation controlee
EP2010156B1 (en) 2006-03-24 2016-11-16 Auxilium International Holdings, Inc. Stabilized compositions containing alkaline labile drugs
CA2647801C (en) * 2006-03-24 2015-04-14 Auxilium Pharmaceuticals, Inc. Process for the preparation of a hot-melt extruded laminate
WO2008106646A2 (en) * 2007-03-01 2008-09-04 Introgen Therapeutics, Inc Methods and formulations for topical gene therapy
HUP0900698A2 (en) * 2009-11-06 2011-06-28 Richter Gedeon Nyrt Pharmaceutical compositions of enhanced stability containing drospirenone and ethynyl estradiol and process for their preparation
RS62297B1 (sr) 2011-11-23 2021-09-30 Therapeuticsmd Inc Prirodne kombinovane hormonske supstitucione formulacije i terapije
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
RU2016143081A (ru) 2014-05-22 2018-06-26 Терапьютиксмд, Инк. Натуральные комбинированные гормонозаместительные составы и терапии
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US9931349B2 (en) 2016-04-01 2018-04-03 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3823070A1 (de) * 1988-07-07 1990-02-22 Kettelhack Riker Pharma Gmbh Selbstklebendes heftpflaster
EP0399432B1 (en) * 1989-05-25 1994-06-22 Takeda Chemical Industries, Ltd. Transdermal therapeutic composition
CA2075517C (en) * 1992-04-01 1997-03-11 John Wick Transdermal patch incorporating a polymer film incorporated with an active agent
DE4310012A1 (de) * 1993-03-27 1994-09-29 Roehm Gmbh Dermales therapeutisches System aus einer schmelzfähigen Poly(meth)acrylat-Mischung
DE4332094C2 (de) * 1993-09-22 1995-09-07 Lohmann Therapie Syst Lts Lösemittelfrei herstellbares Wirkstoffpflaster und Verfahren zu seiner Herstellung
AU702593B2 (en) * 1994-09-14 1999-02-25 Minnesota Mining And Manufacturing Company Matrix for transdermal drug delivery
WO1996008255A1 (en) * 1994-09-14 1996-03-21 Minnesota Mining And Manufacturing Company Transdermal device for delivery of levonorgestrel
DE19526864A1 (de) * 1995-07-22 1997-01-23 Labtec Gmbh Hormonpflaster
HUP9902673A3 (en) * 1996-03-25 2001-04-28 Lohmann Therapie Syst Lts Transdermal therapeutic system with small application-area thickness and great flexibility, and production process
US5762956A (en) * 1996-04-24 1998-06-09 Rutgers, The State University Of New Jersey Transdermal contraceptive delivery system and process
DE19653605C2 (de) * 1996-12-20 2002-11-28 Roehm Gmbh Haft- und Bindemittel für dermale oder transdermale Therapiesysteme und dessen Verwendung zur Herstellung eines transdermalen Therapiesystems

Also Published As

Publication number Publication date
ES2197495T3 (es) 2004-01-01
CN1269717A (zh) 2000-10-11
DE19728516C2 (de) 1999-11-11
NZ502351A (en) 2002-09-27
AU8805598A (en) 1999-01-25
EP1003477A2 (de) 2000-05-31
WO1999001109A2 (de) 1999-01-14
CA2294788A1 (en) 1999-01-14
EP1003477B1 (de) 2003-04-09
AU749326B2 (en) 2002-06-20
DE19728516A1 (de) 1999-01-07
KR100381997B1 (ko) 2003-04-26
DE59807891D1 (de) 2003-05-15
WO1999001109A3 (de) 1999-03-25
BR9815510A (pt) 2002-02-05
JP2002510315A (ja) 2002-04-02
ATE236623T1 (de) 2003-04-15
CA2294788C (en) 2005-06-21
ZA985863B (en) 1998-10-19
KR20010021495A (ko) 2001-03-15
US6555131B1 (en) 2003-04-29
IL133762A0 (en) 2001-04-30
PT1003477E (pt) 2003-08-29

Similar Documents

Publication Publication Date Title
ATE236623T1 (de) Transdermales therapeutisches system (tts) enthaltend ammoniogruppenhaltige (meth)acrylatpolymere zur verabreichung von levonorgestrel
PL324552A1 (en) Plaster for pecutaneous administration of hormones
FI962770A0 (fi) Transdermaalinen laite, joka sisältää polyvinyylipyrrolidonia liukoisuutta parantavana aineena
NO982764L (no) Oppfinnelse og anordning for transdermal anordning for avgivelse av flurbiprofen
DK1003490T3 (da) Transdermalt terapeutisk system (TTS) til indgivelse af kønssteroidhormoner
ATE263577T1 (de) Transdermales verabreichungssystem
ATE372146T1 (de) System zur verabreichung von medikamenten mit veränderbarer rate
DK1570823T3 (da) Transdermalt plaster med buprenorphin til anvendelse i behandling af smerter til et doseringsinterval på mindst 4 dage
NO20015614L (no) Transdermalt terapeutisk system (TTS) som inneholder tolterodin
ATE238778T1 (de) Transdermales therapeutisches system zur abgabe von hormonen
PL330212A1 (en) Preparation administered by transcutaneous absorption
PL352361A1 (en) Microcontainer system based on polysiloxanes and ambiphyle solvents
DE69731882D1 (de) Transdermal verabreichtes dextromethorphan als hustenmittel
DK1063983T3 (da) Transdermalt terapeutisk system (TTS) indeholdende oxybutynin
DE59608150D1 (de) Transdermales therapeutisches system (tts) zur verabreichung von testosteron
HUP9903340A2 (hu) Trimegeszton transzdermális adagolására szolgáló új eszköz, és eljárás előállítására
ATE280575T1 (de) Transdermales therapeutisches system zur anwendung von candesartan
WO2001041771A3 (de) Acetylsalicylsäure enthaltendes transdermales system zur behandlung von migräne
PL332035A1 (en) Transdermal therapeutic system including an estriol-containing composition of active substances
DK0859595T3 (da) Terapeutisk præparat til transdermal indgivelse af aktive sfoffer gennem huden
BG100702A (en) Device and method for the antagonization of the toxic effect of lidocaine on the central and the vegitative nervous system